相关实验视频

Updated: Jun 6, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

对于舌头状细胞癌的放射疗法的创新

Songling Hu^1,2,3, Xiaofei Li^4,5,6, Bin Yang^4,5

¹Department of Preventive Dentistry, Shanghai Stomatological Hospital & School of Stomatology, Fudan University, 1258 Fuxing Middle Road, Shanghai, 200001, China. 18111140002@fudan.edu.cn.

Journal of translational medicine

|November 29, 2024

概括

干预放射学 (IR) 增强了舌状细胞癌 (TSCC) 放射治疗的敏感性. 由TMEM147和SPHK1介导的IR诱导的信号传递促进了自和亡,改善了治疗结果.

科学领域:

在瘤学瘤学.
放射学放射学是一门学科.
分子生物学分子生物学

背景情况:

放射治疗的敏感性对于舌状细胞癌 (TSCC) 患者的预后至关重要.
了解干预性放射学 (IR) 治疗的机制对于优化TSCC治疗至关重要.

研究的目的:

阐明TSCC中IR治疗背后的特定分子机制.
调查信号传导,TMEM147和SPHK1在对TSCC细胞和瘤的IR诱导影响中的作用.

主要方法:

对TSCC细胞和携带瘤的小鼠进行了IR.
定量蛋白质组学和生物信息学分析确定了差异性蛋白质.
免疫沉证实了TMEM147和SPHK1.1之间的相互作用.
在体外和体外测试评估了细胞增殖,细胞亡,自和信号传递.

主要成果:

红外线治疗导致细胞内水平增加.
TMEM147表达是上调的,而SPHK1在IR之后是下调的.
红外线增强了自和亡,这取决于水平,TMEM147和SPHK1.
调节TMEM147或SPHK1影响了IR诱导的自和亡.

结论:

介导的TMEM147和SPHK1调节在TSCC中IR诱导的自和亡中起着关键作用.
这一途径表明了改善TSCC中放射治疗敏感性的新机制.

关键词:

自自是一种自的过程.是一种干预性放射学是干预性的放射学.这就是SPHK1的原因.在TMEM147中,我们可以使用TMEM147.舌头状细胞癌瘤

更多相关视频

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...